𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differences in uptake and metabolism of retinoic acid between estrogen receptor-positive and -negative human breast cancer cells

✍ Scribed by Kosuke Okamoto; Fausto Andreola; Maria V. Chiantore; Robert L. Dedrick; Luigi M. De Luca

Publisher
Springer
Year
2000
Tongue
English
Weight
164 KB
Volume
46
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF-κB and estrogen receptor α interactio
NF-κB and estrogen receptor α interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells
✍ Nathalie Gionet; Deidre Jansson; Sylvie Mader; M.A. Christine Pratt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

## Abstract Estrogen receptor (ER)‐positive breast cancer cells have low levels of constitutive NF‐κB activity while ER negative (−) cells and hormone‐independent cells have relatively high constitutive levels of NF‐κB activity. In this study, we have examined the aspects of mutual repression betwe

Estrogen regulated expression of the p21
Estrogen regulated expression of the p21Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells
✍ Soma Mandal; James R. Davie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

## Abstract The cyclin‐dependent kinase inhibitor protein p21^Waf1/Cip1^ is a potent tumor suppressor. Here, we demonstrate that estradiol regulates the p21^Waf1/Cip1^ gene. Estradiol induces p21^Waf1/Cip1^ mRNA expression within 30–60 min independent of new protein synthesis in the estrogen recept

Quercetin induces type-II estrogen-bindi
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines
✍ G. Scambia; S. Mancuso; P. Benedetti Panici; R. De Vincenzo; G. Ferrandina; G. B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

## Abstract We show that flavonoids positively regulate type‐II estrogen‐binding site (type‐ll EBS) levels both in MCF‐7 (ER‐positive) and in MDA‐MB231 (ER‐negative) breast‐cancer cells. Type‐ll EBS were measured by a whole‐cell assay at 4°C for 2.5 hr using [^3^H]‐estradiol as tracer. In both cell

Estrogen receptor-negative breast cancer
Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid
✍ M. Saeed Sheikh; Zhi-Ming Shao; Jian-Chyi Chen; Arif Hussain; Anton M. Jetten; J 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 968 KB

We and others have shown previously that retinoic acid (RA) selectively inhibits the growth of estrogen receptor (ER)-positive human breast carcinoma (HBC) cells and ER-negative cells are refractory to RA inhibition o f growth. The ER-negative cells inherently express lower levels of RARa and retino

Regulation of androgen receptor gene exp
Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells
✍ Rosemary E. Hall; Wayne D. Tilley; Michael J. McPhaul; Robert L. Sutherland 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 993 KB

Although the androgen receptor (AR) has been detected by ligand-binding assays, there is little known about the expression and regulation of the AR gene in human breast-cancer cells. AR mRNA, measured by Northern analysis in 18 cell lines, was found to be expressed predominantly in oestrogen-and pro